Annual EBITDA
-$3.63 M
+$279.00 K+7.14%
December 1, 2023
Summary
- As of February 7, 2025, SILO annual EBITDA is -$3.63 million, with the most recent change of +$279.00 thousand (+7.14%) on December 1, 2023.
- During the last 3 years, SILO annual EBITDA has fallen by -$1.23 million (-51.28%).
- SILO annual EBITDA is now -186.65% below its all-time high of $4.18 million, reached on December 31, 2021.
Performance
SILO EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$927.70 K
+$2200.00+0.24%
September 1, 2024
Summary
- As of February 7, 2025, SILO quarterly EBITDA is -$927.70 thousand, with the most recent change of +$2200.00 (+0.24%) on September 1, 2024.
- Over the past year, SILO quarterly EBITDA has dropped by -$127.90 thousand (-15.99%).
- SILO quarterly EBITDA is now -115.28% below its all-time high of $6.07 million, reached on December 1, 2021.
Performance
SILO Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$3.71 M
-$268.60 K-7.81%
September 1, 2024
Summary
- As of February 7, 2025, SILO TTM EBITDA is -$3.71 million, with the most recent change of -$268.60 thousand (-7.81%) on September 1, 2024.
- Over the past year, SILO TTM EBITDA has dropped by -$187.40 thousand (-5.32%).
- SILO TTM EBITDA is now -182.58% below its all-time high of $4.49 million, reached on March 1, 2022.
Performance
SILO TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
SILO EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +7.1% | -16.0% | -5.3% |
| 3 y3 years | -51.3% | -16.0% | -5.3% |
| 5 y5 years | -280.9% | -16.0% | -5.3% |
SILO EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -186.7% | +7.1% | -115.3% | +44.1% | -182.6% | +18.7% |
| 5 y | 5-year | -186.7% | +7.1% | -115.3% | +44.1% | -182.6% | +18.7% |
| alltime | all time | -186.7% | +7.1% | -115.3% | +44.1% | -182.6% | +18.7% |
Silo Pharma EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$927.70 K(-0.2%) | -$3.71 M(+7.8%) |
| Jun 2024 | - | -$929.90 K(+16.3%) | -$3.44 M(-2.3%) |
| Mar 2024 | - | -$799.80 K(-23.9%) | -$3.52 M(-2.9%) |
| Dec 2023 | -$3.63 M(-7.1%) | -$1.05 M(+59.5%) | -$3.63 M(-14.4%) |
| Sep 2023 | - | -$659.10 K(-34.8%) | -$4.24 M(-7.1%) |
| Jun 2023 | - | -$1.01 M(+11.8%) | -$4.56 M(+8.4%) |
| Mar 2023 | - | -$904.70 K(-45.5%) | -$4.21 M(+7.7%) |
| Dec 2022 | -$3.91 M(-193.3%) | -$1.66 M(+68.9%) | -$3.91 M(-202.1%) |
| Sep 2022 | - | -$983.20 K(+49.3%) | $3.83 M(-11.3%) |
| Jun 2022 | - | -$658.40 K(+9.2%) | $4.32 M(-3.9%) |
| Mar 2022 | - | -$602.90 K(-109.9%) | $4.49 M(+7.3%) |
| Dec 2021 | $4.18 M | - | - |
| Dec 2021 | - | $6.07 M(-1329.1%) | $4.19 M(-268.4%) |
| Sep 2021 | - | -$493.90 K(+2.3%) | -$2.49 M(-2.4%) |
| Jun 2021 | - | -$482.80 K(-46.9%) | -$2.55 M(-21.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | -$908.60 K(+51.3%) | -$3.25 M(+30.1%) |
| Dec 2020 | -$2.40 M(+152.2%) | -$600.60 K(+8.0%) | -$2.50 M(+12.6%) |
| Sep 2020 | - | -$556.10 K(-53.2%) | -$2.22 M(+15.1%) |
| Jun 2020 | - | -$1.19 M(+660.6%) | -$1.93 M(+96.3%) |
| Mar 2020 | - | -$156.30 K(-51.2%) | -$983.60 K(+3.5%) |
| Dec 2019 | -$950.40 K(-0.2%) | -$320.40 K(+20.9%) | -$950.40 K(-13.8%) |
| Sep 2019 | - | -$265.00 K(+9.5%) | -$1.10 M(+6.4%) |
| Jun 2019 | - | -$241.90 K(+96.5%) | -$1.04 M(-6.7%) |
| Mar 2019 | - | -$123.10 K(-74.0%) | -$1.11 M(+14.5%) |
| Dec 2018 | -$951.90 K(+122.4%) | -$472.90 K(+138.6%) | -$969.50 K(+53.8%) |
| Sep 2018 | - | -$198.20 K(-37.3%) | -$630.30 K(+20.3%) |
| Jun 2018 | - | -$315.90 K(-1905.1%) | -$523.80 K(+151.9%) |
| Mar 2018 | - | $17.50 K(-113.1%) | -$207.90 K(-7.8%) |
| Dec 2017 | -$428.00 K | -$133.70 K(+45.8%) | -$225.40 K(+145.8%) |
| Sep 2017 | - | -$91.70 K | -$91.70 K |
FAQ
- What is Silo Pharma annual EBITDA?
- What is the all time high annual EBITDA for Silo Pharma?
- What is Silo Pharma annual EBITDA year-on-year change?
- What is Silo Pharma quarterly EBITDA?
- What is the all time high quarterly EBITDA for Silo Pharma?
- What is Silo Pharma quarterly EBITDA year-on-year change?
- What is Silo Pharma TTM EBITDA?
- What is the all time high TTM EBITDA for Silo Pharma?
- What is Silo Pharma TTM EBITDA year-on-year change?
What is Silo Pharma annual EBITDA?
The current annual EBITDA of SILO is -$3.63 M
What is the all time high annual EBITDA for Silo Pharma?
Silo Pharma all-time high annual EBITDA is $4.18 M
What is Silo Pharma annual EBITDA year-on-year change?
Over the past year, SILO annual EBITDA has changed by +$279.00 K (+7.14%)
What is Silo Pharma quarterly EBITDA?
The current quarterly EBITDA of SILO is -$927.70 K
What is the all time high quarterly EBITDA for Silo Pharma?
Silo Pharma all-time high quarterly EBITDA is $6.07 M
What is Silo Pharma quarterly EBITDA year-on-year change?
Over the past year, SILO quarterly EBITDA has changed by -$127.90 K (-15.99%)
What is Silo Pharma TTM EBITDA?
The current TTM EBITDA of SILO is -$3.71 M
What is the all time high TTM EBITDA for Silo Pharma?
Silo Pharma all-time high TTM EBITDA is $4.49 M
What is Silo Pharma TTM EBITDA year-on-year change?
Over the past year, SILO TTM EBITDA has changed by -$187.40 K (-5.32%)